Ligand validation:7XRE

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 7XRE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XRE_NAD_E_401	52%	3%	0.167	0.926	3.87	2.31	19	10	4	0	100%	1
7XRE_NAD_D_401	42%	4%	0.197	0.919	3.83	2.28	19	9	4	0	100%	1
7XRE_NAD_B_401	40%	3%	0.214	0.925	4.14	2.46	18	12	6	0	100%	1
7XRE_NAD_C_401	35%	3%	0.194	0.884	3.89	2.37	19	11	4	0	100%	1
7XRE_NAD_F_401	18%	4%	0.228	0.812	3.82	2.3	19	8	3	0	100%	1
7XRE_NAD_A_401	10%	4%	0.235	0.739	3.84	2.15	19	8	10	0	100%	1
7XR9_NAD_B_401	64%	4%	0.158	0.959	3.78	2.3	17	9	6	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.